Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Storm Newton

Drug that slows onset of type 1 diabetes licensed for use in UK-first

Type 1 diabetes needs constant management to keep blood sugar within range (Alamy/PA) -

A groundbreaking drug that slows down the development of type 1 diabetes has been licensed for use in the UK.

Teplizumab can allow patients to live “normal lives” without the need for insulin injections.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.